Venue: Brussels, Belgium
This three day course will focus on the challenges of high-quality cancer clinical trials involving various treatment modalities, imaging and biomarkers. The course will address the methodology and the operational issues of clinical trials in cancer. The future of drug development, market access and new forms of partnerships in oncology will receive special attention.
The first two days of the EORTC-PHARMED-PHARMATRAIN course introduces professionals to these modern developments and lead directly into advanced discussions during the final day. The final day is oriented towards physicians, specialists in oncology, and pharmaceutical industry representatives already engaged in the development of cancer pharmaceuticals.
More information on EORTC-PHARMED-PHARMATRAIN Course website